TBK1 and neoplasm: Given the vital role of IFN‐I in ME49Δompdc‐induced anti‐tumor immunotherapy, and abolishing GRA4 in ME49 enhances host IFN‐I responses by targeting TBK1, we hypothesized that vaccination with ME49Δompdc/gra4 could be more effective in preventing tumor growth.